Darren McDonald, MD
Otolaryngology · Minneapolis, MNNPI 1700863982
Payments from drug & device makers
What this record shows
Stryker accounts for 62.2% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2019 at $1,160 and has fallen 88.3% since, to $135 in 2025.
Across 24 payments — averaging $64.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$959
- Medtronic$150
- GSK$111
- Intersect ENT, Inc.$107
- Regeneron Healthcare Solutions, Inc.$61
- Amgen$33
- plus $121 from 6 others
What the payments were for
- Travel & lodging$91059%
- Food & beverage$63341%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 3 | $959 |
| Medtronic | 1 | $150 |
| GSK | 6 | $111 |
| Intersect ENT, Inc. | 2 | $107 |
| Regeneron Healthcare Solutions, Inc. | 3 | $61 |
| Amgen | 2 | $33 |
| Optinose US, Inc. | 2 | $30 |
| Hologic Sales And Service, LLC | 1 | $29 |
| Merck | 1 | $23 |
| AstraZeneca | 1 | $16 |
| Sanofi | 1 | $13 |
| Itamar Medical Inc | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- 1588 HD 3 CHIP CAMERA$910
- FUSION$150
How this compares
$1,543 in reported general payments places this provider in the 70th percentile of 181 otolaryngology providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 103 | $3,211 |
| Ofloxacin | 41 | $1,416 |
| Fluticasone Propionate | 81 | $943 |
| Azelastine Hcl | 33 | $932 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 17 | $772 |
| Cefdinir | 23 | $460 |
| Betamethasone Dipropionate | 11 | $282 |
| Methylprednisolone | 38 | $236 |
| Oxycodone Hcl | 16 | $177 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 15 | $152 |
| Montelukast Sodium | 11 | $142 |
| Cephalexin | 15 | $86 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 14 | $82 |
| Prednisone | 14 | $53 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Minneapolis
- Samuel LevineMinneapolis$151K
- George GodingMinneapolis$143K
- Michael PaparellaMinneapolis$22K
- Oleg FroymovichMinneapolis$20K
- Robert TibesarMinneapolis$6K
- Nissim KhabieMinneapolis$6K
- Benjamin OstranderMinneapolis$4K
- Neal GodseMinneapolis$2K
- Karin EvanMinneapolis$2K
- Kolin RubelMinneapolis$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.